Journal article
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
Abstract
BACKGROUND: Transient increases in blood eosinophil counts have been observed in dupilumab clinical trials.
OBJECTIVE: To assess eosinophil counts and eosinophilia-related treatment-emergent adverse events (TEAEs) across 11 dupilumab clinical trials, comparing adult and adolescent patients with asthma and adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP), atopic dermatitis, and eosinophilic esophagitis.
Authors
Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N
Journal
The Journal of Allergy and Clinical Immunology In Practice, Vol. 10, No. 10, pp. 2695–2709
Publisher
Elsevier
Publication Date
10 2022
DOI
10.1016/j.jaip.2022.05.019
ISSN
2213-2198